Impact of CGM on people with severe hypoglycaemia
Research type
Research Study
Full title
Assessment of the Impact of Real-time Continuous Glucose Monitoring on People Presenting with Severe Hypoglycaemia (AIR-CGM)
IRAS ID
240039
Contact name
Nick Oliver
Contact email
Sponsor organisation
IMPERIAL COLLEGE LONDON AND IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Good glucose control in type 1 diabetes is associated with a reduced risk of diabetes complications and self monitoring of glucose levels is an important component of achieving and maintaining glucose control. Continuous glucose monitoring (CGM) improves overall glucose control in all age groups when used continuously, and reduces the incidence of low blood glucose (hypoglycaemia) in people with good glucose control.
Hypoglycaemia is one of the commonest metabolic complications of type 1 diabetes and, if it occurs frequently, people can become less able to recognise the symptoms of hypoglycaemia. This reduced awareness of hypoglycaemia has significant risks including seizures, coma and even death, and has an impact on people's ability to drive and function.
In type 1 diabetes real-time continuous glucose monitoring (CGM) improves overall glucose control in all age groups when used continuously, reduces hypoglycaemia in people with an HbA1c <7.0%, and may reduce severe hypoglycaemia.
This clinical study proposes to assess the impact of the Dexcom G6 realtime CGM and will focus on people having a recent episode of severe hypoglycaemia (within 72hrs of enrolment on study)
REC name
London - Bromley Research Ethics Committee
REC reference
18/LO/1525
Date of REC Opinion
26 Oct 2018
REC opinion
Further Information Favourable Opinion